Chondromodulin-I (ChM-I) is suggested in higher vertebrate systems to function as a key regulatory protein for cartilage development. To further understand the process of chondrogenesis and the function of ChM-I, we have cloned the zebra®sh cDNA for chondromodulin-1 (chm1) and have mapped the chm1 gene locus. The expression pro®le of chm1 was determined during zebra®sh embryonic development and compared to that of type II collagen (col2a1). Maternal chm1 transcripts were detected before midblastula transition and zygotic expression of chm1 was ®rst observed in the notochord at the 10-somite stage. At later developmental stages, chm1 expression was detected in areas surrounding the otic vesicles, in the developing craniofacial cartilage elements, and in the chondrogenic region of the pectoral ®ns. q
Results and discussion
Chondromodulin-I (ChM-I) is a 25 kDa secreted glycoprotein. In higher vertebrate systems ChM-I stimulates the growth and maturation of chondrocytes and inhibits vascular invasion into cartilage during endochondral bone formation (Hiraki et al., 1991 (Hiraki et al., , 1997 (Hiraki et al., , 1999 Dietz et al., 1999; Shukunami et al., 1999a,b) .
To learn more about cartilage development and the function of ChM-I, we have cloned and sequenced the fulllength cDNA for the zebra®sh ChM-I ortholog (chm1) (Fig. 1 ). Similar to ChM-I in higher vertebrates, the mature zebra®sh Chm1 protein consists of 117 amino acid residues encoded as the C-terminal portion of a larger membranespanning precursor protein and is preceded by the conserved processing signal (RKRR) (Fig. 1A) . The N-glycosylation site and all eight cysteine residues are conserved across species, suggesting that these residues are important for Chm1 structure and function (Fig. 1A) .
Zebra®sh provide a powerful experimental model for the genetic dissection of gene functions as illustrated by the recent large-scale ENU-mutagenesis screens and the resulting identi®cation of developmentally important genes (Driever et al., 1996; Haffter et al., 1996; Knapik, 2000) . In the present study, we used radiation hybrid mapping to place the zebra®sh chm1 locus in a unique location on linkage group 9 (Fig. 1B) . Thus, chm1 can now be considered a candidate gene for cartilage and/or vascular mutations that show genetic linkage to this chromosomal region. The chm1 locus in zebra®sh is syntenic to human 13q14-q21 (http:// www.ncbi.nlm.nih.gov/omim/) and mouse chromosome 14 (http://www.ncbi.nlm.nih.gov/Homology/).
The phylogenetic tree con®rms that zebra®sh chm1 is more closely related to ChM-I in other species than it is to tenomodulin (TeM), a novel ChM-I-related gene (Fig.1C ) (Shukunami et al., 2001) . In addition, a single band is detected by Southern blot analysis (data not shown). These results suggest that zebra®sh chm1 is the ortholog gene of ChM-I in higher vertebrates.
This study provides the ®rst description of the chm1 gene expression pattern in a lower vertebrate. In situ hybridization experiments revealed that chm1 is ubiquitously distributed as a maternally derived transcript (data not shown). This observation was con®rmed using reverse transcription±polymerase chain reaction (RT±PCR) analysis, which speci®cally detected chm1 transcripts in embryos at several different stages before midblastula transition (Fig. 2) .
To further understand the expression pattern of chm1 at later developmental stages, we conducted parallel in situ hybridization experiments using a probe for type II collagen (col2a1), the predominant protein in cartilage extracellular matrix (Yan et al., 1995) . Zygotic expression of both col2a1 and chm1 was ®rst detected in the notochord, with chm1 appearing three hours later than col2a1 (Fig. 3) . At later (Hiraki et al., 1991) , human (Hiraki et al., 1999) , mouse (Shukunami et al., 1999a) and chicken (Shukunami et al., 1999b) ChM-I precursors. The zebra®sh sequence possesses 39, 39, 38 and 39% overall identity with the previously cloned bovine, human, mouse and chicken orthologs, respectively. Conserved amino acid residues are shaded. Gaps indicated by hyphens were introduced for optimal alignment. The putative transmembrane domain in each precursor is underlined. Chm1 shows the highest sequence identity within the 63-amino-acid stretch at the C-terminal portion from Phe 224 to Val 286 in zebra®sh. This portion exhibits 75, 75, 73, and 71% identity with that of bovine, human, mouse, chicken ChM-I. Conserved cysteine residues in the mature ChM-I are denoted by an asterisk. The potential N-linked glycosylation site is indicated in bold. The mature peptide is generated by cleavage at the processing signal site (connecting bar). GenBank accession numbers for the aligned sequences are as follows: zebra®sh chm1, AF322374; bovine ChM-I, M65081; human ChM-I, AB006000; mouse ChM-I, U43509; chicken ChM-I, AF027380. (B) Radiation hybrid mapping of zebra®sh chm1. The LN54 radiation hybrid panel and web-based RHMAPPER (http:// mgchd1.nichd.nih.gov:8000/zfrh/beta.cgi) (Hukriede et al., 1999) were used to place zebra®sh chm1 on linkage group 9 (LOD score of 14.3) at a distance of 5.98 cR (approximately 885 kilobases) from the SSLP marker Z10166. (C) Phylogenetic tree based on the amino acid sequences of the open reading frames of ChM-I and TeM (Shukunami et al., 2001 ). The tree was generated by UPGMA method using the whole amino acid sequences of the known ChM-I and TeM proteins. The branch length and the number above each arm represent the value estimated by UPGMA algorithm and show evolutionary genetic distance between two sequences. Fig. 2 . Expression of chm1 mRNA transcripts determined by RT±PCR. Nested RT±PCR was used to amplify chm1 transcripts from RNA samples isolated from 8-cell (1.25 hpf, lane1), 128-cell (2.25 hpf, lane 2), and 1000-cell (3 hpf, lane 3) stage embryos. A DNA fragment of expected size (358 bp) was ampli®ed in each case. As a positive control, the second-round primers were used to amplify chm1 transcripts from reverse-transcribed RNA of 48-hpf embryos (lane 4). As a negative control, 20 ng of genomic DNA isolated from a zebra®sh embryo (5 dpf) was used as a template for the nested PCR reactions (lane 5). Equal amounts of the ®nal PCR reactions for each sample were analyzed by agarose gel electrophoresis and compared with the migration of standard DNA size markers (100 bp DNA ladder, Gibco BRL) (lane M). Fig. 3 . Expression of chm1 and col2a1 mRNA during zebra®sh embryonic development. Embryos 11±16 hpf are shown from the dorsal view with anterior to the left (A±H). Embryos 18±36 hpf are shown from a lateral view of the tail (I±N) and high-magni®cation lateral view of the trunk (O,P). Zygotic transcription of col2a1 and chm1 is ®rst detected in the notochord at the 3-somite stage (11 hpf, B) and 10-somite stage (14 hpf, E), respectively (®lled arrows). Between 13 and 16 hpf, col2a1 expression spreads into the paraxial mesoderm (D,F,H; open arrows). The expression of chm1 and col2a1 in the notochord (n) at 18 hpf (I,J,O) begins to diminish in a rostral to caudal direction between 24±36 hpf (K±N,P). By 24 hpf, chm1 expression is detected within the hypochord (h) (K,P; ®lled arrows) and col2a1 expression is readily visible in both the hypochord and¯oorplate (f) (L, ®lled arrows). By 36 hpf, chm1 and col2a1 are expressed in the hypochord (®lled arrows) and the most caudal cells of the notochord (M,N). f,¯oorplate; h, hypochord; n, notochord. Scale bars: A±N, 100 mm; O,P, 50 mm.
stages, chm1 was expressed in areas surrounding the developing ears, in the developing craniofacial cartilage elements, and in the mesenchymal condensation regions of the pectoral ®ns (Fig. 4) . Col2a1 was more widely expressed in mesoderm and mesenchymal tissues (Figs. 3 and 4L; data not shown). Fig. 4 . Expression of chm1 and col2a1 in staged zebra®sh embryos. (A±C) Chm1 expression in ear regions. By 24 hpf, chm1 is expressed in mesodermal regions surrounding the developing otic vesicles (ov) (A; ventral view; n indicates notochord). The expression has shifted to the posterior-ventral portion surrounding the otic vesicle at 48 hpf (B; lateral view, anterior toward left) and at 5 dpf, chm1 expression is particularly strong in mesodermal regions adjacent to the maculae (C; lateral view, anterior toward left, am indicates anterior macula). (D±H) Chm1 expression in craniofacial chondrogenic regions. Chm1 is expressed in the developing trabeculae (arrows) at 40 hpf (D; ventral view, m indicates mouth). At 48±60 hpf, chm1 expression is observed throughout the pharyngeal cartilage and the pharyngeal arches are clearly distinguished by 60 hpf (E,F; lateral views, anterior toward left). Cross sections (8 mm) of wholemount stained embryos show chm1 expression in the ethmoid plate (arrow) (G; e indicates eyes) and more posteriorly in the parachordal cartilage that surrounds the otic vesicles (H). (I±L) Expression of chm1 and col2a1 in the pectoral ®n. Section of the pectoral ®n at 48 hpf shows that chm1 expression is restricted to the chondrogenic region (arrow) (I; 8-mm cross section). Chm1 expression is strongest in the proximal endoskeletal disc (arrow) (J; lateral view, distal toward top; K, dorsal view, distal toward right). In contrast, the expression of col2a1 extends throughout the entire ®n mesenchyme (L, dorsal view, distal toward right). Scale bars: A,C,I, 50 mm; B,D,E,G,H,J±L, 100 mm; F, 200 mm.
